Impellam Group plc (IPEL.L) Research
Impellam Group plc, founded in Luton, UK, in 2008, is a global enterprise specializing in human capital management, staffing solutions, and outsourced people-related services. Its operations span the United Kingdom, North America, mainland Europe, and Australasia. The company's diverse activities are organized into four key segments. The Global Managed Services division offers comprehensive outsourced recruitment, overseeing the entire talent acquisition process from strategic design and implementation to coordination and reporting, operating under brands such as Comensura, Guidant Global, and Flexy. The STEM segment focuses on specialist contract and permanent recruitment within science, technology, engineering, and medicine, placing professionals like scientists, clinicians, engineers, IT, and digital experts through brands including Lorien, Carbon60, Bartech, and SRG. Regional Specialist Staffing addresses a broad range of general and specialized roles, supplying personnel for positions such as warehouse operatives, administrative staff, call centre agents, legal professionals, drivers, educators, culinary experts, and HR and marketing specialists, primarily via brands like Blue Arrow, Tate, Career Teacher, and Chadwick Nott. Finally, the Healthcare segment provides extensive workforce solutions for the medical sector, encompassing everything from temporary and permanent placements for doctors, nurses, care workers, and allied health professionals to managed services, staff bank management, occupational health, insourcing, social care, and home care services, prominently featuring Medacs Healthcare, Global Medics, and Litmus Workforce Solutions.
Market snapshot
- Symbol
- IPEL.L
- Price
- $875
- Day change
- +4.17%
- Market cap
- $389.3M
- P/E ratio
- 47.03x
- 52-week range
- 0.0-950.0
- Sector
- Industrials
- Industry
- Staffing & Employment Services
Peer companies
Open Impellam Group plc (IPEL.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.